Clovis Oncology Announces First Quarter 2014 Operating Results

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BOULDER, Colo.--(BUSINESS WIRE)--Clovis Oncology, Inc. (NASDAQ:CLVS) reported financial results for its first quarter ended March 31, 2014, and provided an update on the Company’s clinical development programs for the rest of 2014.

“This is an exciting time for our clinical development programs and I am proud of what our team has accomplished to date,” said Patrick J. Mahaffy, President and CEO of Clovis Oncology.

Help employers find you! Check out all the jobs and post your resume.

Back to news